SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

Medically reviewed by Mary Choy, PharmD Key Takeaways Insulin is needed to manage your blood sugar levels if you have type 1 ...

Eli Lilly will cut the price of its most commonly prescribed insulin products by 70% and expand a program that caps patient costs at $35 per month, the company said on Wednesday. "While the current ...

Humalog (insulin lispro) and Humulin N (insulin isophane human) are brand-name prescription* medications. They’re approved by the Food and Drug Administration (FDA) to help treat type 1 and type 2 ...

NovoLog (insulin aspart) and Humalog (insulin lispro) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in certain ...

If you have diabetes, your doctor might suggest Humalog (insulin lispro) as a treatment option for your condition. Along with other questions you may have about the drug, you could be wondering about ...

Improved Health Outcomes Noted with Dulaglutide Therapy Lilly announced the availability of lower-priced, non-branded versions of Humalog® Mix75/25™ KwikPen® (insulin lispro protamine and insulin ...

Lower-priced versions of Humalog Mix 75/25 KwikPen (insulin lispro protamine and insulin lispro injectable suspension 100Units/mL) and Humalog Junior KwikPen (insulin lispro injection 100Units/mL) ...

Please provide your email address to receive an email when new articles are posted on . Lilly announced Tuesday that it will offer “authorized generic” versions ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to insulin lispro ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to insulin lispro ...

DANBURY, CT-- Biodel Inc. (BIOD) announced positive preliminary results from Study 3-152, a Phase 2a clinical trial comparing Biodel's proprietary, concentrated insulin formulation BIOD-531 to ...